SCO-spondin oligopeptide inhibits angiogenesis in glioblastoma

Romain Bibes, Stéphane Gobron, François Vincent, Carole Mélin, Nicolas Vedrenne, Aurélie Perraud, Francois Labrousse, Marie-Odile Jauberteau, Fabrice Lalloué

Open source

DOI
10.18632/oncotarget.20837
Published
2017-09-12
Container
Oncotarget
Publisher
Impact Journals, LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.18632/oncotarget.20837,
  title = {SCO-spondin oligopeptide inhibits angiogenesis in glioblastoma},
  author = {Romain Bibes and Stéphane Gobron and François Vincent and Carole Mélin and Nicolas Vedrenne and Aurélie Perraud and Francois Labrousse and Marie-Odile Jauberteau and Fabrice Lalloué},
  year = {2017},
  journal = {Oncotarget},
  doi = {10.18632/oncotarget.20837},
  url = {https://doi.org/10.18632/oncotarget.20837}
}

RIS

TY  - JOUR
TI  - SCO-spondin oligopeptide inhibits angiogenesis in glioblastoma
AU  - Romain Bibes
AU  - Stéphane Gobron
AU  - François Vincent
AU  - Carole Mélin
AU  - Nicolas Vedrenne
AU  - Aurélie Perraud
AU  - Francois Labrousse
AU  - Marie-Odile Jauberteau
AU  - Fabrice Lalloué
PY  - 2017
JO  - Oncotarget
DO  - 10.18632/oncotarget.20837
UR  - https://doi.org/10.18632/oncotarget.20837
ER  - 

APA

Bibes, R., Gobron, S., Vincent, F., Mélin, C., Vedrenne, N., Perraud, A., Labrousse, F., Jauberteau, M., & Lalloué, F. (2017). SCO-spondin oligopeptide inhibits angiogenesis in glioblastoma. Oncotarget. https://doi.org/10.18632/oncotarget.20837

Source records